Filtered By:
Vaccination: AIDS Vaccine
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 1157 results found since Jan 2013.
The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
Cell Rep. 2023 Mar 15;42(4):112307. doi: 10.1016/j.celrep.2023.112307. Online ahead of print.ABSTRACTAnimal reservoirs of sarbecoviruses represent a significant risk of emergent pandemics, as evidenced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Vaccines remain successful at limiting severe disease and death, but the potential for further coronavirus zoonosis motivates the search for pan-coronavirus vaccines. This necessitates a better understanding of the glycan shields of coronaviruses, which can occlude potential antibody epitopes on spike glycoproteins. Here, we compare the structure o...
Source: IAVI Rep - March 27, 2023 Category: Infectious Diseases Authors: Joel D Allen Dylan P Ivory Sophie Ge Song Wan-Ting He Tazio Capozzola Peter Yong Dennis R Burton Raiees Andrabi Max Crispin Source Type: research
Viral hepatitis in persons living with HIV in the post-COVID era
AIDS Rev. 2023;25(1):1-13. doi: 10.24875/AIDSRev.M23000061.ABSTRACTCoinfection with hepatitis viruses A to E is frequent in persons living with HIV (PLWH) and causes significant morbidity and mortality. Oro-fecal transmissible hepatitis A and E mostly produce acute self-limited episodes in poor income regions and in non-vaccinated travelers. In high-income countries, outbreaks of hepatitis A occur in men having sex with men (MSM) and chronic hepatitis E is occasionally reported among PLWH with severe immunodeficiency. Chronic hepatitis B, C, and D are frequent in PLWH in highly endemic regions and globally in persons who i...
Source: AIDS Reviews - March 23, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Octavio Corral Pablo Barreiro Source Type: research
